NANO MRNA Co.,Ltd. (TYO:4571)

NANO MRNA Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008
Net Income	-	-777	-1,308	-494.79	-524.48	-494.03
Depreciation & Amortization	-	1	-	13.1	15.76	14.83
Other Amortization	-	-	-	3.18	-	-
Loss (Gain) From Sale of Assets	-	69	2	0.03	-1.63	0
Loss (Gain) From Sale of Investments	-	-42	228	-	-	-
Other Operating Activities	-	1	43	0	-0	0.52
Change in Accounts Receivable	-	7	20	37.37	-42.96	3.34
Change in Inventory	-	-	32	-10.64	109.74	-78.3
Change in Accounts Payable	-	19	4	2.49	4.68	-2.86
Change in Other Net Operating Assets	-	137	-108	-2.74	-17.71	-31.69
Operating Cash Flow	-	-585	-1,087	-452	-456.62	-588.17
Capital Expenditures	-	-	-	-2.44	-2.97	-14.21
Sale (Purchase) of Intangibles	-	-	-	-5.65	-1.5	-4.41
Investment in Securities	-	878	1,204	-	-	-
Other Investing Activities	-	-85	3	0.02	0.47	0.01
Investing Cash Flow	-	793	1,207	-8.07	-4	-18.61
Issuance of Common Stock	-	3	-	97.37	74.99	643.08
Financing Cash Flow	-	3	-	97.37	74.99	643.08
Foreign Exchange Rate Adjustments	-	54	59	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	33	-	-	-0
Net Cash Flow	-	265	212	-362.69	-385.63	36.3
Free Cash Flow	-	-585	-1,087	-454.43	-459.59	-602.38
Free Cash Flow Margin	-	-433.33%	-538.12%	-385.70%	-129.96%	-229.29%
Free Cash Flow Per Share	-	-8.32	-15.51	-35.59	-36.76	-66.63
Cash Income Tax Paid	-	2	2	2.42	2.42	1.9
Levered Free Cash Flow	-	-377	-	-228.59	-266.83	-395.59
Unlevered Free Cash Flow	-	-377	-	-228.59	-266.83	-395.59
Change in Net Working Capital	-109	-162	-	-71.15	-54.27	108.97

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.